ALLOKIN-ALPHA HOME-MADE ANTIVIRUS NEW-GENERATION DRUG FOR HERPES AND PAPILLOMA VIRAL INFECTION (HPV) TREATMENT FAREWELL TO VIRUS! RussianRU EnglishEN
UkranianUKR KoreanKOR
AzerbaijaniAZ
INSTRUCTION FOR USE Видео о проблеме впч PATIENT FEEDBACK
SECTION FOR SPECIALISTS

Herpes Zoster

All the information contained on this informational resource is intended exclusively for practitioners and cannot be used by the site visitors for self-diagnosing and prescribing treatment without a previous consultation with the doctor.

The background of Herpes Zoster

The infection caused by the varicella - zoster virus (VZV) is implemented by droplets. The primary manifestation of infection at young age is caused by the clinical picture of varicella (V), followed by a latent stage of virus persistence in the body (macrophages of periferic blood, liver, neurons, etc.), and under certain conditions there is a reactivation of the virus with manifestation of different clinical forms, one of which is Herpes Zoster (HZ) (I. G. Belianska, 1996; A. G. Kolomiets, et al., 1992).

The reproduction of Herpes Simplex and Herpes Zoster occurs in polymorphonuclear leukocytes and monocytes. Communication with leukocytes provides the virus protection against the factors of humoral immunity and creates real preconditions for further dissemination (I. F. Barinsky, 2004; A. G. Kolomiets, et al., 1992). Virus HZ is also found in erythrocytes, in which the formation of inclusionsare has been formed. It is shown that more than half of the cases of HZ is related to the patients older than 50 years (V. A. Isakov et al., 2006; N. V. Sizova et al., 2003).

It is known that the reaction of the humoral immunity is not decisive in the suppression of relapse of HZ, and only partially protects against exogenous virus. The reactivation risk of VHZ increases sharply in individuals with immunodeficiencies of different origins (V. A. Isakov et al., 2004; A. G. Rakhmanova, et al., 1997). The clinical picture of HZ syndrome of postzoster neuralgia (PZN) has a great importance, which can occur in 20-30% of patients and can persist from 3 months to several years after suffering from HZ, which attaches the importance to post-infectious immune-mediated mechanisms in the genesis of development.

Read more:

Ask your gynecologist if he (she) has an experience in treatment of human papillomavirus infection to the complete removal of human papilloma virus from the body?

Homepage   |   Feedback   |   Site Map   |   Job Vacancies   |   Contacts
© 2004—2020 Brand-Pharm Ltd. All information contained on this website is intended only for medical specialists and cannot be used by visitors for self-diagnosis and treatment. Consult your physician, do not start self-medication!
The website creation and promotion: Alisa Design
Яндекс.Метрика